LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹725 Cr | ₹637 Cr | ₹555 Cr | ₹487 Cr | ₹437 Cr |
What is the latest Total Liabilities ratio of LINCOLN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹725 Cr |
Mar2023 | ₹637 Cr |
Mar2022 | ₹555 Cr |
Mar2021 | ₹487 Cr |
Mar2020 | ₹437 Cr |
How is Total Liabilities of LINCOLN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹725 Cr | 13.97 | |
Mar2023 | ₹637 Cr | 14.77 | |
Mar2022 | ₹555 Cr | 13.81 | |
Mar2021 | ₹487 Cr | 11.60 | |
Mar2020 | ₹437 Cr | - |
Compare Total Liabilities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,107.5 Cr | -0.1% | -0.8% | -28.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.1% |
-0.8% |
-28.5% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses